TRVI

Trevi Therapeutics, Inc.

Pharmaceuticals · Pharmaceuticals

$263.60 sample

-1.78 (-0.67%) 1D

Market cap

$225.0B

Price as of

2026-10-05

Latest filing

8-K · 2026-09-03

Alerts

8

Price$263.60 +4.00% 3M daily closessample

284.32250.84

2026-07-082026-07-302026-08-212026-09-112026-10-05

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Sep 30INSInsider sell: Chief Financial Officer
Sep 23INSInsider sell: Chief Financial Officer
Sep 17INSInsider sell: Chief Financial Officer
Sep 14INSInsider buy: EVP, Operations
Sep 03SECForm 144 filed
Aug 26INSInsider sell: Director
Aug 17INSInsider sell: EVP, Operations
Aug 12SEC10-Q filed

Sign up to see the real TRVI record →

Company facts

SEC EDGAR registration

Name: Trevi Therapeutics, Inc.
Sector: Pharmaceuticals
Industry: Pharmaceuticals
Smart-money score: -5sample, -100 to +100
Reporting currency: USD

Who is positioning in TRVI

sample

Insiders: 25 insider transactions over 90 days, net selling, $138.4M
Congress: 2 members traded over 90 days
Institutions · 13F: 12 funds hold $5.0B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$12.3B +19.9% y/y

Q4 2024Q3 2026

Inventory$7.2B +11.5% y/y

Q4 2024Q3 2026

Accounts receivable$5.5B +16.5% y/y

Q4 2024Q3 2026

Total debt$14.7B +9.6% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $185.0B -12.0% 3M
Sample peer B: $76.9B +6.8% 3M
Sample peer C: $107.9B -3.8% 3M
Sample peer D: $222.2B +1.9% 3M
Sample peer E: $91.4B +11.1% 3M